Amazon has launched a new GLP-1 weight management program through its One Medical network, integrating obesity treatment into primary care while expanding access to both telehealth services and a range of branded medications.
Amazon launched a comprehensive GLP-1 weight management program through its One Medical primary care network.
Emerging Pharma Leaders nominations are now open!
Do you know someone who can make tough decisions that continue to face manufacturers? Are they destined to change the future of pharma?
Nominate a colleague with impressive leadership and career intentions – even yourself! – for the Pharmaceutical Executive 2026 Emerging Pharma Leaders Awards.
On the heels of the announcement, shares of telehealth rival Hims & Hers Health slid 6% as investors weighed the competitive implications of the retail giant's entry into the obesity care market.2
The GLP-1 Management Program, available now at Amazon One Medical locations across the U.S., integrates weight management into patients' broader primary care relationships instead of offering it as a standalone service.1
The program includes pre-visit screening, structured consultations, regular follow-up visits, integrated monitoring, and evidence-based treatment protocols. The model was designed to allow clinicians to manage how weight loss intersects with cardiovascular health, metabolic conditions, and overall health as part of an ongoing care relationship.
For patients who are not Amazon One Medical primary care members, the company is also offering on-demand, 24/7 telehealth prescription renewals for existing GLP-1 prescriptions for $29 via message consultation or $49 for video care.1
The telehealth option is limited to prescription renewals and is not available for new prescriptions.
As part of the program Amazon is offering a full range of approved GLP-1 weight management medications, including the newly FDA-approved oral pills
The program also offers injectable options such as, Wegovy, Zepbound auto-injector, and Zepbound KwikPen which are available with cash-pay pricing starting at $299 per month. All medications are eligible for delivery to all 50 states, with same-day delivery options currently available in nearly 3,000 cities and towns and expanding to nearly 4,500 by the end of 2026.1
"Providing customers with fast, convenient medication access and clear, transparent pricing is integral to how Amazon Pharmacy is transforming the pharmacy experience," said Tanvi Patel, vice president and general manager of Amazon Pharmacy. "By expanding access to the latest GLP-1 medications with upfront, clear pricing, we're making it easier for customers to get the treatments their health care providers prescribe and to stay on those medications because they are delivered reliably directly to patients."
The launch puts Amazon in direct competition with telehealth companies that have built significant businesses around GLP-1 medication access such as Hims & Hers Health, whose shares fell 6% following the announcement.2 Hims & Hers has been one of the most prominent players in the direct-to-consumer GLP-1 space, yet the company has faced its own headwinds in recent months after being required to
Obesity affects more than 40% of U.S. adults and contributes to nearly $173 billion in annual medical costs, and Amazon is framing the program as a direct response to the fragmented care many patients currently experience when seeking GLP-1 treatment.
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
